Essentials of Mucosal Immunology
- 1st Edition - July 22, 1996
- Latest edition
- Editors: Martin F. Kagnoff, Hiroshi Kiyono
- Language: English
Essentials of Mucosal Immunology presents basic concepts as well as new and exciting advances in mucosal immunology and inflammation, the development of mucosal vaccines, and th… Read more
Essentials of Mucosal Immunology presents basic concepts as well as new and exciting advances in mucosal immunology and inflammation, the development of mucosal vaccines, and the role of the immune system in mucosal disease. Specific chapters highlight novel approaches to the treatment of autoimmune disease, including the use of oral tolerance; approaches to and vectors for new vaccines; and current concepts in mucosal inflammation and its role in inflammatory bowel disease and ulcer disease.
- Contains the most current research on mucosal immunology and is comprehensive in scope
- Includes ideal coverage of both the basic and clinical aspects of the mucosal immune system
- Provides an understanding of the mucosal immune system with regard to new treatments and preventative methods, including vaccine development
- Includes contributions from an international team of experts
Antigen Processing and Presentation in Mucosal Associated Tissues. Role of Epithehelial Cells in Mucosal Immunity. Mucosal T Lymphocytes and Lymphocytes Migration. Mucosal Inflammation. Mucosal Infection. Mucosal Vaccines.
- Edition: 1
- Latest edition
- Published: July 22, 1996
- Language: English
MK
Martin F. Kagnoff
Affiliations and expertise
University of California, San Diego, La Jolla, California, USAHK
Hiroshi Kiyono
University of Alabama, Birmingham, U.S.A. and Osaka University, Japan
Since the 1970s, Professor Kiyono has been investigating and characterizing unique features of the mucosal immune system to establish mucosal immunology as an area of the immunology field as well as to develop effective and safe mucosal vaccines against infectious diseases and mucosal immune therapies against allergic and inflammatory diseases. He recently developed cold-chain- and needle-free rice-based vaccines (MucoRice) with the cooperation of agricultural researchers. The vaccine antigens exogenously expressed in MucoRice are temperature-stable for at least 2.5 years and are resistant to digestive enzymes, thus they effectively induce vaccine antigen-specific protective immunity in both systemic and mucosal compartments against toxins produced by pathogenic microorganisms (e.g., cholera toxins). Additionally, his efforts aim to clarify the immunological cross-talk between the mucosal immune system and mucosal environmental factors (e.g., commensal bacteria and dietary materials) in immunological homeostasis. These studies will lead to the development of novel immune therapies against mucosal immune diseases, such as food allergy, rhinitis, and inflammatory bowel diseases.
Affiliations and expertise
The Institute of Medical Science, The University of Tokyo
University of California, San Diego
Chiba UniversityRead Essentials of Mucosal Immunology on ScienceDirect